GlassScriptPhysician profile
Kelsea Hough
NPI 1861129892
$1,130.18
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $288 · 2023: $748 · 2024: $94.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $842.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $842.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $164.77 | 2022-2023 | Breztri, Farxiga |
| Lilly USA, LLC | $111.77 | 2022-2023 | Mounjaro, Trulicity, Jardiance |
| Pfizer INC. | $110.18 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $91.02 | 2022-2023 | |
| Abbvie INC. | $85.14 | 2023 | |
| Novartis Pharmaceuticals Corporation | $74.73 | 2023 | |
| Indivior INC. | $51.02 | 2023-2024 | Sublocade |
| Sanofi-Aventis U.S. LLC | $45.15 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.72 | 2022 | |
| Astellas Pharma US INC | $38.87 | 2023 | Myrbetriq, Veozah |
| Novo Nordisk INC | $36.69 | 2023 | Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $35.38 | 2023 | Steglatro, Belsomra, Vaxneuvance |
| Amgen INC. | $25.06 | 2023 | Evenity, Prolia |
| C. R. Bard, INC. & Subsidiaries | $24.54 | 2022 | |
| Dexcom, INC. | $24.33 | 2023 | Dexcom G6 Transmitter |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $23.85 | 2023 | Krystexxa |
| Hologic Sales and Service, LLC | $20.95 | 2022 | |
| Lifescan, INC. | $19.97 | 2023 | |
| Exact Sciences Corporation | $19.86 | 2023 | Cologuard Collection Kit |
| Scilex Pharmaceuticals INC. | $18.76 | 2023 | Ztlido |
| Heartflow, INC. | $18.39 | 2022 | |
| Sumitomo Pharma America, INC. | $17.70 | 2023 | Gemtesa |
| Biohaven Pharmaceutical Holding Company LTD. | $17.54 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelsea Hough listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.